11 Recruiting Trials

Clinical Trials
for Heart Disease in Washington

11 clinical trials for Heart Disease are currently recruiting participants at study sites in Washington. Study-related care is provided at no cost.

11
Recruiting trials
6
Study sites
4
Cities
9
Industry-sponsored
1
Phase 2
2
Phase 3

Heart Disease clinical trials in Washington: what to expect

Heart disease trials cover heart failure, coronary artery disease, atrial fibrillation, high cholesterol and lipoprotein(a), and the devices and procedures used to treat them. The largest are outcomes trials: thousands of people take a study medicine or placebo on top of their usual treatment for several years while the trial counts heart attacks, strokes and hospital stays. Smaller studies test new heart failure drugs, cholesterol-lowering injections given a few times a year, cardiac rehabilitation programs and monitoring devices.

In Washington, recruiting heart disease studies are concentrated in Seattle, Bellevue, Renton and Silverdale. 9 of the 11 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who heart disease trials usually look for

Listings define the condition precisely: an ejection fraction range for heart failure, a heart attack or stent within a recent window, cholesterol still above target on a statin, or a lipoprotein(a) level above a threshold. They usually ask that your current heart medicines have been stable for a month or more. Common exclusions are a very recent procedure, advanced kidney disease and another illness that limits life expectancy. Ages generally run from 18 with no upper limit.

What taking part involves

Screening includes an ECG, blood work and often an echocardiogram. Outcomes trials are long but light: a pill or injection added to your treatment, visits every three to six months and phone check-ins between. Drug trials for heart failure run three to twelve months with monthly visits. Device trials involve a procedure and follow-up imaging. Your existing heart medicines continue throughout; study treatment and tests are free, and travel is usually reimbursed.

Questions worth asking the study team

Whether anything about your current treatment would change; how long the trial runs and how often you must come in; what is being measured and what you will be told about your own results; and whether your cardiologist will receive updates.

Showing 11 of 11 recruiting Heart Disease trials in Washington

Abbott Structural Heart Device Registry
N/A Los Angeles, California +4 sites NCT06590467
This trial is looking for patients who need or have had heart device implants. Participants will help gather information about the safety and performance of specific heart devices used in hospitals.
Recruiting
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
PHASE3 Phoenix, Arizona +4 sites NCT05918211
This trial is looking for adolescents aged 12 to under 19 who have had the Fontan procedure. Participants will take either udenafil or a placebo to help assess its safety and effectiveness.
Recruiting
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
NA Los Angeles, California +4 sites NCT07114718
This trial is looking for infants under 6 months who have a congenital heart defect that needs a special stent to help blood flow. Parents or legal representatives will need to give consent for their child to participate.
Recruiting
Autus Valve Continued Access Study (CAS)
NA Los Angeles, California +4 sites NCT07466745
This trial is looking for children aged 18 months to 16 years who need surgery to replace their pulmonary valve. Participants will have regular check-ups over 10 years to see how well the Autus Valve works as they grow.
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
N/A Birmingham, Alabama +4 sites NCT02852031
This trial is looking for newborns diagnosed with Hypoplastic Left Heart Syndrome (HLHS) who are meant to have a specific heart surgery called the Norwood procedure. The goal is to gather information to help improve care for these infants.
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
PHASE3 La Jolla, California +4 sites NCT06563895
This trial is looking for adults who carry a specific genetic variant that can lead to a heart condition but have not yet shown any symptoms. Participants will receive an experimental drug called acoramidis to see if it can prevent heart issues.
Recruiting
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
PHASE2 Seattle, Washington +4 sites NCT06080074
This trial is looking for children with severe heart failure to test a device called Cardiohelp. Participants will receive support from this device and may be asked to use one of two different blood thinners during their care.
Recruiting
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
PHASE1 Dothan, Alabama +4 sites NCT06164730
This trial is looking for patients with a specific type of high cholesterol or early heart disease. Participants will receive a treatment called VERVE-102 to see how safe it is and how it works in lowering cholesterol levels.
Recruiting
EFS of the DUO System for Tricuspid Regurgitation
NA Phoenix, Arizona +4 sites NCT05913908
This trial is looking for adults with severe tricuspid regurgitation who are still having symptoms despite treatment. Participants will be evaluated for the safety and effectiveness of a new valve system called the DUO System.
Recruiting
MDR - PMCF Study for Taperloc Complete Stems
N/A Bellevue, Washington +2 sites NCT04028687
This trial is looking for patients who have had hip surgery using Taperloc Complete stems. Participants will help gather information about the safety and effectiveness of this treatment over time.
Recruiting

Where the Heart Disease studies are in Washington

  • Seattle Children's Hospital, Seattle5 trials
  • University of Washington Medical Center, Seattle2 trials
  • Clinical Study Center, Renton1 trial
  • Pacific NorthWest Retina (Silverdale), Silverdale1 trial
  • Proliance Orthopaedics and Sports Medicine, Bellevue1 trial
  • University of Washington, Seattle1 trial

Counts are recruiting studies listing at least one site in Washington, from ClinicalTrials.gov, refreshed every two days.

Heart Disease clinical trials in Washington: common questions

How many Heart Disease clinical trials are recruiting in Washington?
TrialFinder currently lists 11 recruiting Heart Disease clinical trials with study sites in Washington. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Heart Disease clinical trials located in Washington?
Study sites for the Heart Disease trials listed on this page include Seattle, Bellevue, Silverdale. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Heart Disease clinical trial in Washington?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Heart Disease trials in Washington also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Heart Disease clinical trial in Washington?
Each study sets its own criteria based on age, Heart Disease diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will I have to stop my heart medicines to join a trial?
Almost never. Heart disease trials add a study treatment to the medicines you already take, and your own cardiologist continues to manage them. A trial that requires a change says so in its listing.
What is a cardiovascular outcomes trial?
A large, multi-year study in which participants take a study medicine or placebo on top of standard care while the trial counts events such as heart attacks and hospital stays. Visits are infrequent, and the drug is provided free throughout.
Can I join a trial after a heart attack or stent?
Yes. Many trials enroll in the weeks after a heart attack or procedure, because that is when the next event is most likely. The window is stated in the listing, so ask soon after discharge.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Heart Disease trials near you in Washington.

Get Matched — Free
No insurance required

Cardiovascular trials study statins, PCSK9 inhibitors, heart failure devices, cardiac rehabilitation protocols, and interventional procedures for coronary artery disease.

All Heart Disease trials →